A detailed history of Clearstead Trust, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Clearstead Trust, LLC holds 511 shares of AZN stock, worth $34,727. This represents 0.01% of its overall portfolio holdings.

Number of Shares
511
Previous 508 0.59%
Holding current value
$34,727
Previous $39,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $230 - $262
3 Added 0.59%
511 $39,000
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $427 - $486
7 Added 1.4%
508 $34,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $194 - $215
3 Added 0.6%
501 $33,000
Q1 2023

May 10, 2023

BUY
$63.15 - $71.6 $442 - $501
7 Added 1.43%
498 $34,000
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $26,032 - $66,653
491 New
491 $27,000
Q2 2018

Aug 20, 2018

SELL
$34.55 - $37.05 $82,229 - $88,179
-2,380 Closed
0 $0
Q2 2017

Aug 21, 2017

BUY
N/A
2,380
2,380 $58,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.